Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
complement C4A (Rodgers blood group) | 0.563 | 0.769 | 1.5E-11 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
C-C motif chemokine ligand 14 | 0.695 | 0.423 | 1.1E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
SAP domain containing ribonucleoprotein | 0.678 | 0.500 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
RNA binding motif protein 39 | 0.686 | 0.462 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
luteinizing hormone/choriogonadotropin receptor | 0.528 | 0.692 | 5.3E-08 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
actinin alpha 4 | 0.508 | 0.808 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
menin 1 | 0.444 | 0.808 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
kallikrein related peptidase 4 | 0.559 | 0.692 | 4.5E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2000 | 2001 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | 0.546 | 0.846 | 4.0E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
kininogen 1 | 0.481 | 0.885 | 3.2E-10 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
bradykinin receptor B2 | 0.585 | 0.808 | 0.12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
jagged canonical Notch ligand 1 | 0.429 | 0.808 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
guanylate cyclase activator 2B | 0.695 | 0.385 | 0.38 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
group | 0.010 | None | < 0.001 | 1 | 2 | 2005 | 2005 | ||||||||
|
neuropeptide S | 0.619 | 0.615 | 1.4E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
solute carrier family 3 member 1 | 0.593 | 0.731 | 7.2E-27 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
alpha-thalassemia/mental retardation syndrome, type 1 | 0.711 | 0.577 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
apolipoprotein A4 | 0.582 | 0.577 | 5.5E-06 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2006 | ||||||||
|
zinc metallopeptidase STE24 | 0.517 | 0.731 | 8.9E-16 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
chymase 1 | 0.514 | 0.692 | 7.6E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
collagen type IV alpha 5 chain | 0.553 | 0.654 | 1.00 |
|
group | 0.110 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
group | 0.010 | None | 1.000 | 1 | 1 | 2008 | 2008 |